0001566028-13-000032.txt : 20131010
0001566028-13-000032.hdr.sgml : 20131010
20131010165222
ACCESSION NUMBER: 0001566028-13-000032
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131008
FILED AS OF DATE: 20131010
DATE AS OF CHANGE: 20131010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HI TECH PHARMACAL CO INC
CENTRAL INDEX KEY: 0000887497
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 112638720
STATE OF INCORPORATION: NY
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 369 BAYVIEW AVENUE
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
BUSINESS PHONE: 5167898228
MAIL ADDRESS:
STREET 1: 369 BAYVIEW AVE.
CITY: AMITYVILLE
STATE: NY
ZIP: 11701
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SELTZER DAVID S
CENTRAL INDEX KEY: 0001054694
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-20424
FILM NUMBER: 131146368
MAIL ADDRESS:
STREET 1: C/O TASHLIK KREUTZER & GOLDWYN PC
STREET 2: 833 NORTHERN BLVD
CITY: GREAT NECK
STATE: NY
ZIP: 11021
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2013-10-08
0000887497
HI TECH PHARMACAL CO INC
HITK
0001054694
SELTZER DAVID S
C/O HI-TECH PHARMACAL CO., INC.
369 BAYVIEW AVENUE
AMITYVILLE
NY
11701
1
1
1
0
CEO, President, Sec'y, Treas.
Common Stock
2013-10-08
4
S
0
23000
43.09
D
1290703
D
Common Stock
2013-10-09
4
F
0
26091
43.09
D
1264612
D
Common Stock
2013-10-09
4
M
0
75000
14.99
A
1339612
D
Common Stock
167445
I
By Spouse and Issue
Common Stock
57482
I
As Trustee of Trust for the Benefit of his Child
Stock Option (Right to Buy)
14.99
2013-10-09
4
M
0
75000
0
D
2004-12-04
2013-12-04
Common Stock
75000
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.06 to $43.12, inclusive. The reporting person undertakes to provide Hi-Tech Pharmacal Co., Inc., any security holder of Hi-Tech Pharmacal Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan
The option became exercisable in four (4) equal installments beginning on the first anniversary of the grant date.
Other than the option reflected on this form, Mr. Seltzer is also the holder of additional options to acquire an aggregate of 475,000 additional shares of Hi-Tech Common Stock, which options were granted on various dates, with various exercise prices, exercise dates and expiration dates.
David S. Seltzer
2013-10-10